EXEL - Exelixis, Inc. - SEC Form 4 Insider Trading Screener

Services - Engineering, Accounting, Research, Management Services - Commercial Physical & Biological Research - EXEL (939767)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
32 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
P2+4+6+22+100
S30-0-1-0+33

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

D
2017-04-03
EXELMarchesi Vincent TDirS - Sale+OE$21.30-10,000120,070-8%-$213,000-4-5
D
2017-03-31
EXELWyszomierski Jack LDirS - Sale+OE$21.57-5,15072,960-7%-$111,086-2-6
2017-03-27
EXELHessekiel JeffreyEVP, GCS - Sale$21.02-6,884267,946-3%-$144,702-10+3
D
2017-03-22
EXELHessekiel JeffreyEVP, GCS - Sale+OE$20.54-23,787274,830-8%-$488,585+2+1+2
D
2017-03-20
EXELFeldbaum Carl BDirS - Sale+OE$21.77-10,00048,721-17%-$217,7000+4+3
D
2017-03-20
EXELPapadopoulos SteliosDirS - Sale+OE$21.66-10,0001,238,471-1%-$216,6000+4+3
D
2017-03-15
EXELWillsey LanceDirS - Sale+OE$22.86-10,000568,273-2%-$228,6000-8-3
D
2017-03-15
EXELSchwab GiselaPres Prod Dev, Med Aff, CMOS - Sale+OE$22.53-50,007172,027-23%-$1,126,6580-8-3
2017-03-13
EXELCohen CharlesDirS - Sale$21.82-10,000238,180-4%-$218,200+5+1-4
D
2017-03-10
EXELMarchesi Vincent TDirS - Sale+OE$21.98-40,000120,070-25%-$879,200+1+1-5
D
2017-03-03
EXELHessekiel JeffreyEVP, GCS - Sale+OE$23.04-100,000246,617-29%-$2,303,678-2-2-4
DM
2017-03-03
EXELMorrissey MichaelPres, CEOS - Sale+OE$22.72-200,000249,523-44%-$4,544,000-2-2-4
2017-03-03
EXELHaley Patrick J.SVP, CommercialS - Sale$23.04-2,500140,400-2%-$57,600-2-2-4
2017-03-03
EXELSenner Christopher J.EVP, CFOS - Sale$22.80-11,000102,181-10%-$250,800-2-5-6
D
2017-03-01
EXELLamb PeterEVP, Scientific Strategy, CSOS - Sale+OE$22.19-45,00089,728-33%-$998,550-2-5-6
DM
2017-03-01
EXELPoste GeorgeDirS - Sale+OE$22.53-76,25077,555-50%-$1,718,185-2-5-6
D
2017-02-01
EXELLamb PeterEVP, Scientific Strategy, CSOS - Sale+OE$18.65-70,00089,680-44%-$1,305,500-1+12+13
D
2017-01-03
EXELLamb PeterEVP, Scientific Strategy, CSOS - Sale+OE$14.65-70,00089,624-44%-$1,025,636+2+21+34
D
2016-12-16
EXELFeldbaum Carl BDirS - Sale+OE$17.03-25,00048,721-34%-$425,750-3-11+7
D
2016-12-09
EXELGarber Alan MDirS - Sale+OE$16.90-7,83261,329-11%-$132,361-2-1+12
DM
2016-12-05
EXELScangos George ADirS - Sale+OE$17.81-204,8941,487,243-12%-$3,649,178+2-2-7
D
2016-12-01
EXELLamb PeterEVP, Scientific Strategy, CSOS - Sale+OE$16.66-70,00089,624-44%-$1,166,200+3-3-16
D
2016-12-01
EXELSchwab GiselaPres Prod Dev, Med Aff, CMOS - Sale+OE$16.73-22,000171,859-11%-$368,060+3-3-16
D
2016-11-09
EXELMorrissey MichaelPres, CEOS - Sale+OE$15.00-200,000251,329-44%-$3,000,000-1+1-4
D
2016-11-09
EXELSchwab GiselaPres Prod Dev, Med Aff, CMOS - Sale+OE$15.00-22,000171,859-11%-$330,000-1+1-4
D
2016-11-09
EXELLamb PeterEVP, Scientific Strategy, CSOS - Sale+OE$13.15-70,00089,624-44%-$920,500-1+1-4
D
2016-08-31
EXELSchwab GiselaPres Prod Dev, Med Aff, CMOS - Sale+OE$10.98-131,155150,247-47%-$1,440,082+5+4+10+99
D
2016-08-04
EXELSchwab GiselaPres Prod Dev, Med Aff, CMOS - Sale+OE$11.00-42,338145,822-23%-$465,718-2-5+3+82
M
2016-05-09
EXELWillsey LanceDirP - Purchase$4.96+60,000568,273+12%+$297,900+6+7+49+148
M
2015-12-10
EXELWillsey LanceDirP - Purchase$4.89+100,000494,975+25%+$488,550+2+5-5+52
D
2015-10-16
EXELLamb PeterEVP, Discovery Research, CSOS - Sale+OE$5.80-51,54950,951-50%-$298,984-50-6-26
DM
2015-10-12
EXELLamb PeterEVP, Discovery Research, CSOS - Sale+OE$5.84-300,87650,951-86%-$1,756,792+3-1+3-22

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top